Iohexol plasma clearance measurement in older adults with chronic kidney disease—sampling time matters

• Published in: Nephrology, dialysis, transplantation Vol. 30; no. 8; pp. 1307 - 1314
• Main Authors: Ebert, Natalie, Loesment, Amina, Martus, Peter, Jakob, Olga, Gaedeke, Jens, Kuhlmann, Martin, Bartel, Jan, Schuchardt, Mirjam, Tölle, Markus, Huang, Tao, van der Giet, Markus, Schaeffner, Elke
• Format: Journal Article
• Language: English
• Published: England 01.08.2015
• Subjects: Adult; Aged; Aged, 80 and over; Biomarkers - blood; Cohort Studies; Contrast Media - metabolism; Contrast Media - pharmacokinetics; Creatinine - blood; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Iohexol - metabolism; Iohexol - pharmacokinetics; Kidney Function Tests; Male; Middle Aged; Renal Insufficiency, Chronic - metabolism; Renal Insufficiency, Chronic - physiopathology; Specimen Handling; Time Factors; Tissue Distribution; measured GFR; 24 hours iohexol clearance; reduced renal function; elderly; GFR measurement protocol
• ISSN: 0931-0509; 1460-2385; 1460-2385
• DOI: 10.1093/ndt/gfv116

Accurate and precise measurement of GFR is important for patients with chronic kidney disease (CKD). Sampling time of exogenous filtration markers may have great impact on measured GFR (mGFR) results, but there is still uncertainty about optimal timing of plasma clearance measurement in patients with advanced CKD, for whom 24-h measurement is recommended. This satellite project of the Berlin Initiative Study evaluates whether 24-h iohexol plasma clearance reveals a clinically relevant difference compared with 5-h measurement in older adults. In 104 participants with a mean age of 79 years and diagnosed CKD, we performed standard GFR measurement over 5 h (mGFR300) using iohexol plasma concentrations at 120, 180, 240 and 300 min after injection. With an additional sample at 1440 min, we assessed 24-h GFR measurement (mGFR1440). Study design was cross-sectional. Calculation of mGFR was conducted with a one compartment model using the Brochner-Mortensen equation to calculate the fast component. mGFR values were compared with estimated GFR values (MDRD, CKD-EPI, BIS1, Revised Lund-Malmö and Cockcroft-Gault). In all 104 subjects, mGFR1440 was lower than mGFR300 (23 ± 8 versus 29 ± 9 mL/min/1.73 m(2), mean ± SD; P < 0.001). mGFR1440 was highly correlated with mGFR300 (r = 0.9). The mean absolute difference mGFR300 - mGFR1440 was 5.9 mL/min/1.73 m(2) corresponding to a mean percentage difference of 29%. In individuals with eGFRCKD-EPI ≤ 30 mL/min/1.73 m(2), percentage difference of mGFR300 and mGFR1440 was even higher (35%). To predict mGFR1440 from mGFR300, we developed the correction formula: mGFR1440 = -2.175 + 0.871 × mGFR300 (1-fold standard error of estimate: ±2.3 mL/min/1.73 m(2)). The GFR estimating equation with the best accuracy and precision compared with mGFR300 and mGFR1440 was the Revised Lund Malmö. In elderly CKD patients, measurement of iohexol clearance up to 5 h leads to a clinically relevant overestimation of GFR compared with 24-h measurement. In clinical care, this effect should be bore in mind especially for patients with considerably reduced GFR levels. A new correction formula has been developed to predict mGFR1440 from mGFR300. For accurate GFR estimates in elderly CKD patients, we recommend the Revised Lund Malmö equation.